Education
About Us
Working with TipRanks
Follow Us
Orthocell Ltd (AU:OCC)
ASX:OCC
OCC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.36 - AU$1.79
Previous CloseN/A
Volume2.26M
Average Volume (3M)751.23K
Market Cap
AU$308.45M
Enterprise ValueAU$266.69M
Total Cash (Recent Filing)AU$30.84M
Total Debt (Recent Filing)AU$657.93K
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding244,800,000
10 Day Avg. Volume583,546
30 Day Avg. Volume751,225
Financial Highlights & Ratios
PEG Ratio-1.47
Price to Book (P/B)13.53
Price to Sales (P/S)0.00
P/FCF Ratio-37.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.00Price Target Upside-20.63% Downside
Rating ConsensusHold
Number of Analyst Covering0
Orthocell Ltd News
PremiumCompany Announcements
Orthocell Ltd Announces Cessation of 250,000 Securities
PremiumCompany Announcements
Orthocell Issues New Shares to Bolster Market Position
PremiumCompany Announcements
Orthocell Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Orthocell Achieves First US Sales for Remplir™ Nerve Repair Product
PremiumCompany Announcements
Orthocell Enhances Leadership Team with Key Executive Appointments
PremiumCompany Announcements
Orthocell Achieves Record Revenue, Eyes US Market Expansion
PremiumCompany Announcements
Orthocell Announces First US Surgery and Rollout of Remplir™
PremiumCompany Announcements
Orthocell Marks Milestone with First US Use of Remplir™Options Prices
Currently, No data available
---
Ownership Overview
3.18% Insiders
―
Mutual Funds
― Other Institutional Investors
96.74% Public Companies and
Individual Investors
OCC FAQ
What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.36 and its highest was AU$1.79 in the past 12 months.
What is Orthocell Ltd’s market cap?
Orthocell Ltd’s market cap is AU$308.45M.
When is Orthocell Ltd’s upcoming earnings report date?
Orthocell Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 38 days.
How were Orthocell Ltd’s earnings last quarter?
Currently, no data Available
Is Orthocell Ltd overvalued?
According to Wall Street analysts Orthocell Ltd’s price is currently Overvalued.
Does Orthocell Ltd pay dividends?
Orthocell Ltd does not currently pay dividends.
What is Orthocell Ltd’s EPS estimate?
Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orthocell Ltd have?
Orthocell Ltd has 244,800,000 shares outstanding.
What happened to Orthocell Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Orthocell Ltd?
Currently, no hedge funds are holding shares in AU:OCC
Orthocell Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$1.00 (-20.63% Downside)
AU$1.00 (-20.63% Downside)
Blogger Sentiment
Bullish
AU:OCC Sentiment 98%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
231.57%
12-Months-Change
Fundamentals
Return on Equity
-29.77%
Trailing 12-Months
Asset Growth
60.70%
Trailing 12-Months
Company Description
Orthocell Ltd
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Technical Analysis
Paradigm Biopharmaceuticals Ltd.
―
Immutep Ltd
―
Dimerix Limited
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―